Medicus Pharma Ltd. - 8-K Filing
Medicus Pharma entered into an exclusive co-development and license agreement with Pfizer for CD228V, including upfront payments of $14M and development funding of $2M. (Items: 1.01 Entry into a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)
Tickers: $MDCX